title: Minimally invasive combined treatment for Parry-Romberg syndrome.
abstract: BACKGROUND
  Facial hemiatrophy, a typical manifestation of Parry-Romberg syndrome, produces massive face asymmetry, causing marked aesthetic damage and severe psychological discomfort, with repercussions to the psychophysical status of the patient. This article presents a successful combined treatment that results in resolution of symptoms and patient satisfaction.
  
  
  METHODS
  The authors proposed a clinic-therapeutic management comprising a customized program of bio-lipo-intense pulsed light (IPL) remodeling.
  
  
  RESULTS
  In 2007, at a 1-year follow-up visit, the patient presented a stable result. She is satisfied with the augmentation treatment, the new volume and contours of the face, and the resolution of the sclerosis and ochrodermia.
  
  
  CONCLUSIONS
  The authors have succeeded with a minimally invasive reconstructive technique for Romberg disease using a customized therapeutic program of poly-L-lactic acid, lipofilling, and IPL therapy. They report a case of good healing without recurrences and complications, with a good cosmetic result, and with satisfaction of the patient.
authors.affiliation: Department of Plastic and Reconstructive Surgery, Sapienza University of Rome, Rome, Italy.
authors.forename: Maria Giuseppina
authors.initials: MG
authors.lastname: Onesti
authors.forename: Cristiano
authors.initials: C
authors.lastname: Monarca
authors.forename: Maria Ida
authors.initials: MI
authors.lastname: Rizzo
authors.forename: Marco
authors.initials: M
authors.lastname: Mazzocchi
authors.forename: Nicolò
authors.initials: N
authors.lastname: Scuderi
mesh_terms: D003131:Combined Modality Therapy; D018450:Disease Progression; D005150:Facial Hemiatrophy / Q000601:surgery* / Q000628:therapy; D005260:Female; D005612:Freeze Drying; D006801:Humans; D007271:Injections, Intradermal; D019344:Lactic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D053685:Laser Therapy / Q000379:methods; D008567:Membranes, Artificial; D019060:Minimally Invasive Surgical Procedures; D011091:Polyesters; D011108:Polymers / Q000008:administration & dosage / Q000627:therapeutic use; D012867:Skin / Q000473:pathology; D050151:Subcutaneous Fat / Q000637:transplantation; D055815:Young Adult
chemical_list: D008567:Membranes, Artificial; D011091:Polyesters; D011108:Polymers; D019344:Lactic Acid; C033616:poly(lactide)